In COVID-19 clinical update #97, Daniel Griffin covers immunity after infection recognized by CDC, outcomes before and after Omicron, infectious viral load in Delta vs Omicron, PCR vs rapid antigen tests, booster interval shortened to 5 months, risk factors for severe outcomes in vaccinated, cross-reactive memory T cells, vaccine effectiveness vs MIS-C, and Rivaroxiban for thromboprophylaxis.
Click arrow to play
Download TWiV 853 (58 MB .mp3, 48 min)
Subscribe (free): iTunes, Google Podcasts, RSS, email
Show notes at microbe.tv/twiv
2 thoughts on “TWiV 853: COVID-19 clinical update #97 with Dr. Daniel Griffin”
Thanks for sharing! Hope this pandemic is a dream…
I want to share this great testimony to the world on how Dr. Kham cured me from HSV1&2 with his herbs, I was nervous when i first contact him about the cure for HSV but i decided to give him a try because i was desperate to get cured and be free from HSV. Dr. Kham prepared the cure and sent it to me through UPS, Which I used just the way Dr. Kham instructed me and thank God today I am a beneficiary to this cure and I went back to the hospital after two weeks of taking the herbs and I tested HSV1&2 Negative. So I will tell you all who are looking for a cure to his/her HSV1&2 that Dr. Kham took research before he could finally get the solution to it and a lot of people are benefiting from him right now. He also cured my friend from HPV. Dr. Kham heals with natural herbs. Please I urge you to contact him now through his Gmail address: dr.khamcaregiver@gmail. com
Comments are closed.